In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.
Your legal rights might be affected by two proposed Settlements, totaling $58 million, in a class action lawsuit (In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724) pending in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback